CVS Health Corp vs Gitlab Inc — how do they compare? CVS Health Corp trades at $93.57 (market cap $119.58B), while Gitlab Inc trades at $41.49 (market cap $7.11B). The key difference: CVS Health Corp is far larger — about 16.8× Gitlab Inc's market cap, and CVS Health Corp pays a 2.84% dividend while Gitlab Inc pays none. Which is the better fit depends on your goals.
| CVS | GTLB | |
|---|---|---|
Market Cap | $119.58B | $7.11B |
Sector | Health | Technology |
52-Week High | $110.60 | $51.04 |
52-Week Low | $65.51 | $19.42 |
Enterprise Value | $181.93B | $5.85B |
Dividend Yield | 2.84% | — |
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →GitLab Inc operates on an all-remote model. The company is a technology company whose primary offering is GitLab, a complete DevOps platform delivered as a single application. GitLab is used by a wide range of organizations. The company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
Read more on GTLB →